Page 1 | Search Results | Blood | American Society of Hematology

1-8 of 8

Sort by

Sort Order Select

Journal Articles

The Potential Role of Emicizuamb Prophylaxis in Severe Von Willebrand Disease

Assaf Arie Barg, Gili Kenet, Tami Livnat, Einat Avishai, Ivan Budnik, MDPhD, Tami Brutman-Barazani, Ilia Tamarin, Aharon Lubetsky, Dalia Bashari, Rima Dardik, PhD, Shadan Lalezari, Mudi Misgav

Blood (2020) 136 (Supplement 1): 20.

https://doi.org/10.1182/blood-2020-138777

Published: 2020

Journal Articles

Factor XI Deficiency Protects Against Atherogenesis

Reut Shnerb, Dror Harats, Ginette Schiby, David Gailiani, Hanna Levkovitz, Ilia Tamarin, Aviv Shaish, Ophira Salomon

Blood (2015) 126 (23): 421.

https://doi.org/10.1182/blood.V126.23.421.421

Published: 2015

Journal Articles

A Simple Two Step Approach for Diagnosis of Heparin Induced Thrmbocytopenia Using 4T Score and PaGIA Testing

Aaron Lubetsky, MD, Gili Kenet, MD, Nurit Rosenberg, PhD, Ilia Tamarin

Blood (2014) 124 (21): 1449.

https://doi.org/10.1182/blood.V124.21.1449.1449

Published: 2014

Journal Articles

Assessment Of The Validation and Performance Of The Cone and Plate(let) Analyzer (CPA) In The Diagnosis Of Von Willebrand's Disease

Aaron Lubetsky, MD MSc, Boris Shenkman, Ilia Tamarin, Naphtali Savion, Phd, David Varon, MD

Blood (2013) 122 (21): 2351.

https://doi.org/10.1182/blood.V122.21.2351.2351

Published: 2013

Journal Articles

Patients with Severe Factor XI Deficiency Have a Reduced Incidence of Venous Thromboembolism.

Ophira Salomon, Ariella Zivelin, Ilia Tamarin, David M. Steinberg, David Varon, MD, Uri Seligsohn, MD

Blood (2009) 114 (22): 3491.

https://doi.org/10.1182/blood.V114.22.3491.3491

Published: 2009

Journal Articles

Patients with Severe Factor XI Deficiency Who Have An Inhibitor or IgA Deficiency Can Undergo Uneventful Major Surgery by a Single Infusion of Low Dose Recombinant Factor VIIa and Use of Tranexamic Acid.

Ophira Salomon, Ilia Tamarin, Tami Livnat, Zeev Horovitz, Joseph Kuriansky, Uriel Martinowitz, Yoram Mor, Uri Seligsohn

Blood (2008) 112 (11): 1215.

https://doi.org/10.1182/blood.V112.11.1215.1215

Published: 2008

Journal Articles

Evaluation of Stability of a Sucrose-Formulated, Full-Length rFVIII for Use in Continuous Infusion Therapy.

Uri Martinowitz, Aaron Lubetsky, Ilia Tamarin, Jacob Luboshitz

Blood (2004) 104 (11): 4114.

https://doi.org/10.1182/blood.V104.11.4114.4114

Published: 2004

Journal Articles

Unique Antiplatelet Effects of a Novel S-Nitrosoderivative of a Recombinant Fragment of von Willebrand Factor, AR545C: In Vitro and Ex Vivo Inhibition of Platelet Function

Aida Inbal, Osnat Gurevitz, Ilia Tamarin, Regina Eskaraev, Angela Chetrit, Ilia Novicov, Monica Feldman, David Varon, Michael Eldar, Joseph Loscalzo

Blood (1999) 94 (5): 1693–1700.

https://doi.org/10.1182/blood.V94.5.1693

Published: 1999

NARROW

The Potential Role of Emicizuamb Prophylaxis in Severe Von Willebrand Disease

Factor XI Deficiency Protects Against Atherogenesis

A Simple Two Step Approach for Diagnosis of Heparin Induced Thrmbocytopenia Using 4T Score and PaGIA Testing

Assessment Of The Validation and Performance Of The Cone and Plate(let) Analyzer (CPA) In The Diagnosis Of Von Willebrand's Disease

Patients with Severe Factor XI Deficiency Have a Reduced Incidence of Venous Thromboembolism.

Patients with Severe Factor XI Deficiency Who Have An Inhibitor or IgA Deficiency Can Undergo Uneventful Major Surgery by a Single Infusion of Low Dose Recombinant Factor VIIa and Use of Tranexamic Acid.

Evaluation of Stability of a Sucrose-Formulated, Full-Length rFVIII for Use in Continuous Infusion Therapy.

Unique Antiplatelet Effects of a Novel S-Nitrosoderivative of a Recombinant Fragment of von Willebrand Factor, AR545C: In Vitro and Ex Vivo Inhibition of Platelet Function

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only